Contemporary OB/GYN is pleased to announce the addition of new members to its distinguished editorial board.
Yalda Afshar, MD, PhD
Dr. Afshar is an assistant professor in the division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, at the University of California, Los Angeles.
“It is such an honor to join a team working tirelessly to disseminate evidence-based best practices to a diverse readership with a simple goal – taking excellent care of the patients in front of us!”
Christine Isaacs, MD
Dr. Isaacs is a general ob/gyn, professor, and Academic Specialist Division Chief at the Virginia Commonwealth University School of Medicine in Richmond, Va. She also is the medical director of Midwifery Services there.
"I'm excited for the opportunity to reflect on the many advancements in our field, to learn from the wisdom of inspirational colleagues, and to contribute to the well-vetted and practical guidance that that supports us as busy clinicians!"
Laura Riley, MD
Dr. Riley is chair of Obstetrics and Gynecology at Weill Cornell Medicine and Obstetrician and Gynecologist-in-Chief at New York Presbyterian Hospital in New York City.
“I am excited to join the editorial board because I have always found the articles in Contemporary OB/GYN to be timely, accurate, and relevant to current practice- always a great resource.”
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More